BlackRock Fund Advisors’s XBiotech XBIT Stock Holding History

BlackRock Fund Advisors’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10.3M	Buy	1,013,917 +98,423	+11%	+$1.31M	﹤0.01%	2557
2016 Q3	$12.3M	Buy	915,494 +44,012	+5%	+$646K	﹤0.01%	2340
2016 Q2	$18.2M	Buy	871,482 +353,253	+68%	+$5.1M	﹤0.01%	2082
2016 Q1	$4.9M	Buy	518,229 +35,711	+7%	+$296K	﹤0.01%	2757
2015 Q4	$5.25M	Buy	482,518 +377,885	+361%	+$4.83M	﹤0.01%	2817
2015 Q3	$1.56M	Sell	104,633 -1,137	-1%	-$19.9K	﹤0.01%	3162
2015 Q2	$1.91M	Buy	+105,770	New	+$2.19M	﹤0.01%	3172

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Fund Advisors's XBIT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its XBiotech (XBIT) stake by 11% in Q4 2016, buying an estimated $1.31M and bringing the position to 1,013,917 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2557.

BlackRock Fund Advisors first reported a position in XBIT in Q2 2015 and has held it in 7 quarters since. The position peaked at $18.2M in Q2 2016. 49 funds tracked by Wall St. Rank hold XBIT as of Q4 2016.

BlackRock Fund Advisors held 1,013,917 shares of XBiotech worth $10.3M as of Q4 2016.
BlackRock Fund Advisors bought 98,423 XBiotech shares in Q4 2016, an estimated $1.31M.
XBiotech made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2557 holding.
BlackRock Fund Advisors first reported a position in XBiotech in Q2 2015 and has held it in 7 quarters since.
BlackRock Fund Advisors's XBiotech position peaked at $18.2M in Q2 2016.
49 funds tracked by Wall St. Rank held XBiotech as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.